Industry News & Updates

Wednesday ~ July 2, 2008

FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler

FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler

Herzliya, Israel and Morris Plains, NJ − The U.S. Food and Drug Administration (”FDA”) today announced the approval of EVOLENCE® for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds. EVOLENCE® is a new advanced collagen-based structural dermal filler, and a first of its kind product. The introduction of EVOLENCE® marks the first dermal filler entry for the Aesthetics Group of OrthoNeutrogena. While new to the United States, EVOLENCE® has been available in other markets such as in Canada, Western and Eastern Europe, Israel, South Korea and Russia since 2004.

“EVOLENCE® represents a new generation of facial fillers, an innovative structural agent providing beautiful, immediate results by replacing the collagen lost with long-lasting, naturally sourced collagen,” said Annie Heremans, M.D., Ph.D., Vice President, responsible for the Company’s research and development of the Medical and Aesthetic Dermatology franchises. “We are pleased to enter the U.S. aesthetic space with a differentiated dermal filler designed for optimal patient outcomes. Given our rich heritage in skin care and and commitment to science, we anticipate EVOLENCE® will be a welcome addition to current aesthetic treatment options.”

EVOLENCE® will be introduced throughout the second half of 2008, in coordination with physician training, to ensure optimal patient satisfaction and outcomes.

EVOLENCE® represents a breakthrough in aesthetics. As one of nature’s most fundamental and abundant building blocks, collagen comprises up to 80% of the dermis and it helps maintain skin strength, structure and support. Collagen naturally breaks down as a person ages, leading to the appearance of wrinkles, lines and folds.

EVOLENCE®, and its proprietary GLYMATRIX™ Technology, uses naturally sourced collagen to replace the body’s lost collagen, adding volume and structural support in depleted areas, for a more naturally youthful appearance. In addition, no pre-test is needed, and GLYMATRIX™ Technology delivers longer-lasting durability than previous collagen dermal fillers.

Results are visible and immediate at the time of treatment, with minimal to no bruising or swelling, allowing physician and patient to gauge the amount of wrinkle correction with more precision. EVOLENCE® is recommended for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds, to be injected in the mid-to-deep dermis.

“We now have a collagen filler that does not require a pre-test and delivers immediate, beautiful and
natural-looking results that last with minimal to little downtime for the patient,” said Z. Paul ” said Z. Paul Lorenc, M.D., F.A.C.S., Assistant Professor of Surgery, New York University School of Medicine and Principal Investigator on the EVOLENCE® U.S. pivotal study. “EVOLENCE® consistent and predictable results for all patients with every treatment.”
About EVOLENCE®

EVOLENCE® is an advanced collagen-based structural dermal filler that provides long-lasting treatment of moderate to deep facial wrinkles and folds, such as nasolabial folds. The results of treatment with EVOLENCE® are immediate, with little to no downtime post-treatment and clinically proven to last through six months. Additional data for 12-month duration approval is being filed with the FDA.

Unlike other dermal fillers that use hyaluronic acid (HA), which absorb water to create their effect, EVOLENCE® is a true structural agent due to its three-dimensional collagen matrix. This collagen structure benefits patients as it is directly linked to the minimal bruising and swelling that might result. EVOLENCE® does not use chemicals for cross-linking like many other products do, but instead uses natural sugar to improve durability. EVOLENCE® collagen is cross-linked through its patented GLYMATRIX™ Technology using the natural sugar, D-Ribose. The GLYMATRIX™ process is designed to:

- Mimic naturally occurring collagen in the skin by creating a true structural framework with natural, durable cross-links to ensure filler longevity
- Provide consistent and predictable results
- Use natural ingredients for natural-looking results

The naturally sourced porcine collagen used in EVOLENCE® is the most genetically similar to human collagen and has been used safely and effectively for decades in various medical applications, including heart valve replacement.

This new generation collagen filler is intended for injection into the mid-to-deep dermis for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds. The most common side effects of EVOLENCE®injections are usually injection-site related and include mild swelling, redness, and pain. Other rare side effects include the development of small areas of firmness under the skin at the treated sites that may be noticed when the areas are pressed upon.

EVOLENCE®® has undergone rigorous testing and has been demonstrated to be safe and effective through clinical studies. For more information on the product, visit www.evolence.com.
About OrthoNeutrogena, Aesthetics Group

EVOLENCE® is marketed in the United States by the Aesthetics Group of OrthoNeutrogena, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., and part of the Johnson & Johnson family of companies. This innovative collagen structural dermal filler was developed by ColBar LifeScience, Ltd., a biotechnology company specializing in reconstructive medicine and tissue engineering. The company has perfected a technique in which collagen, a main building block of living organisms, can be purified and transformed so as to create a variety of products that are structurally stable and safe for medical applications. ColBar LifeScience Ltd., is also subsidiary of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Aesthetics Group of OrthoNeutrogena
800.EVOLENCE (386-5362)
www.evolence.com

Source: OrthoNeutrogena

Sothys Introduces Eco-Certified Organic Beauty Range September 2008

Nature: Beauty’s Favorite Muse
Sothys Introduces Eco-Certified Organic Beauty Range September 2008

New York, NY – Green living has gone from novelty to mainstream in just a few short years. Where organic food, clothing, and cosmetics were once looked upon with skepticism, they are now expected to perform equally if not better than their non-organic counterparts. Today, consumers are becoming increasing savvy about their eco-friendly purchases and require validation that the products they are using are truly friendly for their bodies and the environment.

Luxury skincare company Sothys began its organic movement in 2006 with the foundation of the Les Jardins Sothys™, a botanical garden in France. “Through the creation of the Sothys botanical garden in the Xaintrie region of France, a multitude of plants have offered unbelievable biodiversity, to the extent that it was named in the European Ecological Heritage of the Natura 2000 project,” says Sothys Chairman Bernard Mas. According to Mas, the creation of an organic beauty line has been a huge project for the entire company, “for Sothys to introduce an organic range, we knew we had to pair nature and science, which took a huge commitment – we didn’t want to put out anything less than a Sothys quality product.”

After two years of research partnered with the local University of Limoges in France, Sothys will introduce five new EcoCert approved organic products in September of 2008. In typical Sothys fashion, every product not only meets EcoCert standards, but also soars above and beyond expectations in terms of efficacy for the skin. According to Mas, “as organic products become more advanced, beauty consumers expect products to be top-of-the-line in terms of both their credibility and effectiveness. Through EcoCert, Sothys has created products that are not only effective in treating the skin but meet the highest standards of organic certification, which is an extremely important factor for consumers living the green lifestyle.”

The Beauty Garden Organic Range by Sothys
The Beauty Garden Range by Sothys will be growing over time, with their initial organic offering including a range of five face and body products formulated with natural ingredients each carrying the EcoCert Organic Cosmetics Label, which guarantees that 95% of the ingredients are of natural origin and a minimum of 10 percent of the ingredients come from organic farming. The Beauty Garden Range by Sothys contains between 99.5 percent and 100 percent natural ingredients. Between 10 percent and 100 percent of those ingredients were grown and harvested using organic farming methods.

Make-Up Removing Fluid with Cherry Bud
A fluid with a light consistency created to smoothly remove facial and neck makeup, while leaving the skin soft, clear and feeling fresh. Price $30

Floral Water with Angelic and Hawthorn
A soft and fresh lotion that’s ideal for completing make-up or mask removal, as well as tone the skin gently and evenly. Price $30

Comfort Mask with Helianthus and Rosemary
A mask for all skin types that awakens the radiance of the complexion, softens the skin and brings instant comfort and softness. Price $34

Gentle Face Care with Helianthus and Rosemary
A gentle facial cream infused with rosemary essential oil. Its texture instantly melts into the skin, providing comfort and radiance to normal and combination skin types, leaving the skin glowing with vitality. By protecting the skin, it helps delay the onset of the first signs of aging. Price $52

Milky Body Fluid with Cherry Bud and Lavender
A fresh and melting texture for a smooth and quenched skin, this body milk envelops the skin with a veil delicately scented with lavender essential oil. Price $36

Actives Organic Substances Found in the Sothys Beauty Garden Range
Each Beauty Garden product contains Sothys’ exclusive Vegetal Moisturizing Activator™ (VMA), which is a moisturizing complex derived from three plants (cherry trees, angelica and hawthorn) and combined with glycerin obtained from plants. VMA reinforces the barrier function of the skin by maintaining hydration of the stratum corneum and protecting the epidermis from outside aggressions. The barrier then protects the skin from environment and aging effects with a scientifically proven hydrating layer – tests performed by Sothys in conjunction with the University of Limoges found the VMA increased hydration of the skin by 34%, which reinforces the barrier function of the skin.

Organic Extract of Cherry Buds
The extract of cherry buds is rich in sugars and inorganic substances and also contains flavonoids. As is the case for all extracts of buds, its richness in growth substances confers regenerating and energizing effects on the skin. In addition, the composition of the extract of cherry buds is recognized for its hydrating properties, which makes it ideal for moisturizing, regenerating and energizing the skin.

Organic Extract of Hawthorn
Hawthorn is a shrub that blossoms in the spring. Hawthorn flowers are white and highly aromatic, which is the source of the organic extract. Hawthorn floral water alleviates stress, is antioxidant, anti-age and venotonic.

Organic Extract of Angelica
The extract of angelica is obtained from the root of the plant. It contains polyphenols, tannins, flavonoids and an essential oil, which helps limit the appearance the first signs of aging, bacteria, and relaxes the epidermis.

Plant Glycerin
Combined with the three plant extracts describe above, it is recommended for its anti-dryness and moisturizing properties.

Helianthus (Organic Sunflower) Oil
Sunflower oil contains essential fatty acids and is particularly rich in Omega-6 and Omega-9, which restore the youth and elasticity of the skin, and combat skin dehydration and aging. It hydrates the skin by reducing transepidermal water loss, restores lipids by reconstituting the fatty acid balance.

Essential Oil of Rosemary
The essential oil of rosemary is recognized as a tonic and stimulant, and can aid cell revitalization and has anti-wrinkle properties.


Essential Oil of Bulgarian Lavender

Essential oil of lavender is recognized for several properties including soothing, calming and relaxing, and aids in the regulation of the nervous system.

Beauty Garden® Organic Spa Treatment with VMA
Sothys introduces the Beauty Garden Organic Spa Treatment, a 40-minute facial performed with Beauty Garden professional products for all skin types. The treatment utilizes Sothys’ model for a combination of professional and home care treatments. The result is skin that is soft and radiant, thanks to consistency in treatment.

The Mas family believes that with the introduction of the Beauty Garden Range, they can help to raise the bar for beauty companies considering joining the organic movement, an achievement that would be a victory for everyone involved. According to Mas, “the Beauty Garden Range is Sothys’ way of melding family tradition with a socially conscious trend. Our beauty garden in France has enabled us to support ecotourism and research, through a love of beauty and the environment.”

ABOUT SOTHYS
In 1946, Sothys was a beauty institute in Paris, where a list of exclusive customers enjoyed fine French products created by Dr. Hotz, a medical biologist. Sothys was acquired by the Mas family in 1966 and chairman Bernard Mas decided to add to the beautiful Sothys range and increase its availability. By 1970 Sothys had entered the United States market under the direction of esthetician Christian Garces. Sothys became an instant hit for estheticians looking for a professional, results- oriented product line. Over two decades later, it continues to be the forerunner in an extremely demanding industry. Much of Sothys’ success is due to its focus on education. Not content to simply sell its products, Sothys offers continuous, complementary education to estheticians and therapists who want to learn not just about the products, but about the industry in general. At the Sothys headquarters in Miami, and at regional Sothys offices across the Nation, classes are offered, with topics ranging from hands-on body workshops to cosmetic chemistry.

Sothys
305.594.4222
www.sothys-usa.com

Source: Sothys

Monday ~ June 2, 2008

Jan Marini Skin Research Introduces Marini Lash™ for Full and Lush Eyelashes

Jan Marini Skin Research Introduces Marini Lash™ for Full and Lush Eyelashes

Jan Marini Revolutionizes Cosmetic Eyelash Enhancement – Again!

San Jose, CA – Jan Marini Skin Research, Inc. (JMSR; www.janmarini.com) today introduced Marini Lash, a revolutionary eyelash formulation designed to give users amazingly gorgeous, dense and lush eyelashes.

In 2005 JMSR revolutionized eyelash enhancement with a technological first that inspired a host of imitators. Now, JMSR sets the pace again by introducing a proprietary and spectacular non-prostaglandin eyelash formulation. JMSR research and development uncovered a recently discovered proprietary peptide which, when combined with other essential factors, produces extraordinary eyelash and brow enhancement.

“For three decades, I have been dedicated to developing products that provide men and women with real solutions for their skin and hair, offering them the full benefit of the latest scientific innovations,” said Jan Marini, president and CEO of Jan Marini Skin Research. “I was overwhelmed by the incredibly passionate response of women worldwide to my previous eyelash enhancement formulas. I am confident that Marini Lash will give everyone spectacular-looking, lush lashes.”

Marini Lash, offered in a mascara-style container, is available through physicians and licensed skin care professionals worldwide.

About Jan Marini Skin Research, Inc.
San Jose, CA-based Jan Marini Skin Research, Inc. (JMSR) is a recognized leader and innovator in skin care, providing state of the art technologies and breakthroughs in medically-based skin care therapies. The JMSR Skin Care Management System is used and trusted by physicians and skin care professionals worldwide to ensure optimum results for their patients and clients. JMSR products range from Glycolic Acid formulas and patented breakthroughs to the state-of-the-art anti-aging properties of the remarkable C-ESTA® family of products, all aimed at addressing aging skin, acne, rosacea and other common skin concerns.

Jan Marini Skin Care Research
408.363.1030
www.janmarini.com

Source: Jan Marini Skin Care Research

Thursday ~ May 22, 2008

The Perfect BOTOX

THE PERFECT BOTOX®

By Gregory Alan Wiener, M.D., F.A.C.S.

Is there such a thing as the “perfect BOTOX®?” One need look no further than glowing, smooth-faced celebrities like Vanessa Williams to see that some BOTOX injections are truly works of art. How can patients achieve similarly perfect BOTOX results?

First, be realistic. A wrinkle-free face would be a dream come true for most patients, but it is also a very unrealistic dream for a patient of 40+ years old. An older woman with absolutely no wrinkles appears artificial, and it is very easy to see that she has had ‘work done.’ Instead, aim for subtle but realistic changes, with minimal and age-appropriate amounts of BOTOX.

Second, remember your individual needs. Depending on your age, facial structure, long-term goals, and collagen, the amount of BOTOX you receive and the location where it is injected will differ. Just because your friend Linda receives BOTOX monthly, this doesn’t necessarily mean that you will need the same treatment. BOTOX application differs from patient to patient—after all, you wouldn’t use the exact same shade of makeup as your friend, so why would you receive the same BOTOX treatment?

One easy way that doctors can determine a patient’s BOTOX needs is to take pictures of their face with a digital camera. Your doctor may try many different angles, and dim and increase the amount of light with each different shot. (Wrinkles will appear differently when the light alternates, which will help to guide your doctor’s decision-making process.) He may also ask you to make a range of facial expressions—from smiling to frowning to grimacing. As you examine the pictures later, you will no doubt see a trend in the wrinkle formation. These little facial clues can help guide you and your doctor in deciphering what your problem areas are and how best to treat them.

Third, remember that you will need less BOTOX as the years go by. During your first year of receiving BOTOX, you should come into your doctor’s office once every 3 months. After you have received BOTOX for 12 months, you only need to come in once every six months. Not only will you need to receive BOTOX less often, you will also need less BOTOX than the previous year. Return patients generally need 20% less BOTOX. As the face becomes accustomed to the treatment, the wrinkles will decrease and slow in growth. Thus, maintaining a youthful, smoother appearance is really quite simple over time—just two office visits a year with minimal BOTOX each time.

Fourth, don’t neglect preventative measures. Research has shown that patients who receive BOTOX when they are younger are more likely to have smoother, natural-looking results than patients who wait until the wrinkles have become fully formed. Preventative BOTOX can actually prevent wrinkles from ever completely forming, meaning that patients need never worry about trying to “undo” wrinkles when it is too late.

Last but not least, the most crucial step in achieving the perfect BOTOX is making sure that you visit only aestheticians and doctors who are licensed in the use of BOTOX. Don’t be fooled into the fun or convenience of receiving BOTOX at a “BOTOX party” from a doctor whom you don’t know. Credentials and a portfolio of the doctor’s work should always be on hand, and all BOTOX should be administered in a sanitary, medical environment.

As long as you take the proper precautions, wrinkle-free, glowing skin can be yours! Turns out, there is such a thing as the “perfect BOTOX!”

Gregory Alan Wiener, M.D. F.A.C.S.
www.TheArtofPlasticSurgery.com

Source: Aesthetic Trends & Technologies, Inc.

Wednesday ~ May 7, 2008

New Age Intervention® Enlighten by Jan Marini Skin Research

New Age Intervention® Enlighten by Jan Marini Skin Research

Brightens and Minimizes Discoloration of Facial Skin
Provides a More Refined, Resurfaced and Illuminated Facial Texture

San Jose, CA – Jan Marini Skin Research, Inc. (JMSR; www.janmarini.com) introduces Age Intervention Enlighten, a remarkable new composition that brightens and encourages the uniform appearance of facial discoloration — even stubborn hyperpigmentation.

“Women often associate fine lines and wrinkles with aging but discoloration is an even more visual sign of the aging process,” explains Jan Marini, president and CEO of Jan Marini Skin Research. “Age Intervention Enlighten is an exceptional brightening technology with de-aging agents that result in refined, rejuvenated and illuminated skin.”

Uneven skin tones and discoloration can age the look of facial skin just as dramatically as lines and wrinkles. Overly pigmented facial areas that may occur due to melasma, cumulative sun exposure and ethnicity are some of the most common and difficult to concerns to treat.

Enlighten contains a combination of two exceptional topical agents that address the appearance of facial discoloration. Enlighten also includes Retinol, a superior retinoid that discourages the production of excess melanin and assists in resolving the appearance of existing facial discoloration. The Retinol also acts as a potent anti-aging tool that provides a more refined, resurfaced and illuminated facial texture.

Enlighten’s exceptional brightening technology and de-aging agents result in the refined, rejuvenated and illuminated skin we all want.

Age Intervention Enlighten is offered in a 1 oz. pump bottle.

Jan Marini Skin Research
408.362.0130
www.janmarini.com

Source: Jan Marini Skin Research

Monday ~ May 5, 2008

BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology

BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology

Technology designed to selectively weaken specific muscles may provide an attractive alternative treatment for frown lines

San Mateo, CA – BioForm Medical, Inc. (NASDAQ: BFRM) announced that it has acquired substantially all of the assets of privately-held, Denver, CO based, Advanced Cosmetic Intervention, Inc. (ACI) and associated technology rights for $12 million cash, plus future royalties and a potential sales-related milestone. This acquisition provides BioForm Medical, a leading medical aesthetics company, with a commercially-available technology for local nerve ablation.

ACI’s device, sometimes also referred to as the GFX device in prior media reports, is currently cleared via a 510(k) by FDA to create RF heat lesions in nerve tissue. The ACI device uses minimally-invasive bi-polar radiofrequency energy selectively to weaken nerve signal transduction with durable effects.

The use of this technology on nerves that control the muscles of the forehead may reduce the appearance of frown lines, or glabellar furrows. BioForm Medical expects to conduct clinical studies specifically intended to support an FDA application seeking clearance to market this product for the treatment of frown lines. The Company expects to also seek a CE mark and certain other international registrations of the ACI device for aesthetics indications.

“We are building a leading medical aesthetics company. We believe this new treatment will offer patients an attractive alternative therapy for the treatment of frown lines. Many patients in our consumer research surveys have indicated that they choose not to receive neurotoxin treatment due to fear of losing facial expressions, or fear of injections with a toxin,” stated Steven Basta, CEO of BioForm Medical. “We believe that the synergy of this product with our Radiesse dermal filler will be terrific. We have a differentiated, long-lasting filler, and in the coming years we hope to offer physicians a new treatment option for frown lines. This is part of our commitment to partnering with physicians to offer them improved aesthetic treatment options that can grow their practices.

This device could appeal to many of the same physicians who select Radiesse dermal filler for their patients, and will leverage our existing sales and marketing organization.” In the acquisition of ACI, BioForm Medical will hire several of ACI’s employees, and retain others as consultants to maintain continuity of this program and to accelerate future product development and commercialization activities. In addition to the up-front consideration, BioForm Medical will pay a single-digit royalty to ACI. The Company anticipates that significant positive revenue impact of this acquisition is not likely until it obtains clearance for the product for aesthetic applications, anticipated to occur in calendar year 2009.

About BioForm Medical, Inc.
BioForm Medical, Inc. is a medical aesthetics company headquartered in San Mateo, California. BioForm is dedicated to bringing doctors and their patients safe and effective products for use in the dermatology, plastic surgery and ENT markets. BioForm’s products include Radiesse®, a long lasting filler for use in facial aesthetics and vocal fold insufficiency, and Coaptite® for treating female stress urinary incontinence which is marketed through a partnership with Boston Scientific Corporation. BioForm has licensed U.S. marketing rights to Aethoxysklerol®, the worldwide leading sclerotherapy agent, which is currently being evaluated in a Phase III clinical trial. BioForm has also licensed BioGlue, a new surgical adhesive product for plastic surgery applications, which is being developed in a partnership with CryoLife, Inc.

BioForm Medical Inc.
866.862.1211
www.bioform.com

Source: BioForm Medical Inc.

Palomar Unveiled New Laser-Assisted Liposuction Platform at the American Society for Laser Medicine & Surgery

Palomar Unveiled New Laser-Assisted Liposuction Platform at the American Society for Laser Medicine & Surgery

BURLINGTON, Mass. - Palomar Medical Technologies Inc. (Nasdaq: PMTI), a leading researcher and developer of light- based systems for cosmetic treatments, announced the unveiling its latest innovation in aesthetic laser technology at the 28th annual conference of the American Society for Laser Medicine & Surgery (ASLMS) in Kissimmee Florida, April 2-6. Palomar displayed a new platform called the Aspire(TM) aesthetic laser platform and Stylus(TM) Sculpter laser-assisted liposuction handpiece in booth #507 in the ASLMS exhibit hall. The Aspire platform will allow Palomar to offer solutions to new procedures which are in high-demand including laser-assisted liposuction. The Aspire platform will complement the broad range of aesthetic applications offered by Palomar’s flagship StarLux(R) 500 laser and pulsed-light platform.

Traditional liposuction is one of the most commonly performed plastic surgery procedures, according to the 2007 survey from the American Society of Aesthetic Plastic Surgery. Laser-assisted liposuction holds out the promise for a better technique due to the laser’s ability to quickly and selectively melt fat and heat surrounding tissue. Palomar’s approach to laser-assisted liposuction with the Aspire platform and Stylus Sculpter handpiece is to utilize unique tip designs and selective and efficient wavelengths for melting fat and providing the desired thermal effects on surrounding tissue.

Chief Executive Officer Joseph P. Caruso commented, “The unveiling of the Aspire platform and Stylus Sculpter handpiece is the culmination of years of research directed to absorption of light by fat. Our system uses optimal wavelengths to melt fat and provide the appropriate amount of heat to the surrounding tissue. As with all Palomar products, the Aspire platform is based on sound scientific principles developed and tested by Palomar’s research and development organization, which is preeminent in the light-based aesthetic industry.”

Mr. Caruso continued, “The Aspire platform is an ideal complement to the StarLux platform for providing opportunities for even more treatment modalities. With the new aesthetic procedures that will be possible with Aspire, and the many popular treatments, including hair removal, skin rejuvenation and skin resurfacing, available with the StarLux(R) 500, practitioners will be able to offer a complete suite of the most-requested aesthetic procedures.”

The Aspire Platform and Stylus Sculpter liposuction laser-assisted handpiece are pending FDA clearance and should be available for shipment in the third quarter 2008.


About Palomar Medical Technologies Inc.

Palomar is a leading researcher and developer of light-based systems for cosmetic treatments. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. In December 2006, Palomar became the first company to receive a 510(k) over-the- counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a new, patented, home use, light-based hair removal device. OTC clearance allows the product to be marketed and sold directly to consumers without a prescription. There are now millions of light-based cosmetic procedures performed around the world every year in physician offices, clinics, spas and salons. Palomar is testing many new and exciting applications to further advance the hair removal market and other cosmetic applications. Palomar is focused on developing proprietary light-based technology for introduction to the mass markets. Palomar has granted The Procter & Gamble Company a non-exclusive License Agreement to certain patents, technology and FDA documents related to the home-use, light-based hair removal field for women. In addition, Palomar has an exclusive development and license agreement with Johnson & Johnson Consumer Companies to develop and potentially commercialize home-use, light-based devices for reducing or reshaping body fat including cellulite, reducing the appearance of skin aging, and reducing or preventing acne.

Palomar Medical
800.PALOMAR (725.6627)
www.palomarmedical.com

Source: Palomar Medical

Bio-Therapeutic Presents the bt-analyze™

Bio-Therapeutic Presents the bt-analyze™

Bio-Therapeutic is pleased to release the bt-analyze™ skin identification system. Part of Bio-Therapeutic’s bt-gear™ line, the bt-analyze™ provides an accurate and essential assessment of the skin’s moisture contents.

The bt-analyze™ is tiny in price and size, but large on performance. Measuring less than 3.5 inches in length the bt-analyze™ weighs less than ¼ of a pound and holds a minuscule price of $95 making it an ideal fit for all forward thinking technologists looking to get their tech on!

Bio-Therapeutic, Inc., the world leader in anti-aging technology, was established in 1974, and is headquartered in Seattle, Washington. With worldwide distribution, Bio-Therapeutic supplies skin therapists with the most cutting edge, age defying technology available today including the Bio-Ultimate Platinum® microcurrent system, Bio-Synthesis™ light activated rejuvenation system, Bio-Oxygen™ oxygen infusion system, Bio-Brasion™ microdermabrasion system, Bio-Dermology™ cellulite system, and bt-GEAR™ Tools and Technology of Convenience. The company is a FDA and ISO registered device manufacturer, and all equipment is safety tested and UL/CSA listed. Ongoing clinical trials with the University of Washington ensure proven efficacy and results.

Bio-Therapeutic
800.971.6438
www.bio-therapeutic.com

Source: Bio-Therapeutic

Sunday ~ May 4, 2008

Artes Medical Plans to Restructure to Cut Costs

Artes Medical plans to restructure to cut costs

Artes Medical plans to restructure but will still expand its ArteFill sales force

NEW YORK (Associated Press) - Medical technology company Artes Medical Inc. said it is restructuring in an effort to reduce costs in line with expected revenue.

The company said the goal is to “re-align” its overall cost structure toward its prior 2008 revenue guidance of $13 million to $16 million. Meanwhile, it will continue expanding its sales force for the injectable implant ArteFill, which is used as a wrinkle treatment.

Artes said it believes it has enough cash, along with anticipated ArteFill sales, to fund the company through the first quarter of 2009.

Shares of Artes fell 8 cents, or 6.7 percent, to close at $1.12.

Artes Medical
888.ARTEFILL (278.3345)
www.artesmedical.com

Source: CNN Money

Monday ~ April 14, 2008

Canfield Imaging Systems Introduces New Facial Imaging System

Canfield Imaging Systems Introduces New Facial Imaging System

Canfield Imaging Systems premieres its latest product: the Reveal™ Imager

Canfield Imaging Systems is now offering the Reveal™ Imager, its latest facial imaging system for skin care professionals. The Reveal Imager is designed to take the highest quality standardized and reproducible medical quality photographs. The system captures images of surface and sub-surface skin and will photograph front, left, and right views. The Reveal Imager is undergoing beta testing in Europe now and will be available in the spring.

A revolutionary new solution for professional skin care consultation, the elegant Reveal Imager was designed for the skin care counter, also making it ideal for spas, medical spas and traditional medical practices. With an easy-to-use and easy-to-learn interface anyone in a skin care office can take professional, repeatable facial photographs. The compact size and light weight also makes it ideal for traveling events, including health fairs.

The Reveal Imager uses the same Canfield proprietary RBX™ Technology employed in research laboratories and high-end skin care practices. With RBX, skin care professionals can detect subsurface vascular (red) and melanin (brown) conditions and develop highly targeted treatment recommendations. The system uses Canfield’s patent-pending IntelliFlash™ technology for both full spectrum and cross-polarized lighting modalities.

According to Doug Canfield, Founder and President of Canfield Imaging Systems, “Skin care professionals around the world asked Canfield to bring the elegance, ease of use, and reporting of market-leading VISIA® Complexion Analysis System to a broader set of businesses. Now, with the Reveal Imager, we can deliver a similar facial imaging experience to more customers and enhance their consultative process.”

The Reveal Imager is available in the US directly from Canfield Imaging Systems and outside the US through distributors worldwide.

ABOUT CANFIELD IMAGING SYSTEMS
Canfield Imaging Systems is a division of Canfield Scientific, Inc., which is the global leader in imaging systems services and products for scientific research and healthcare applications. Canfield Scientific, Inc serves the pharmaceutical, biotechnology, cosmetics, medical and skincare industries.

Canfield Imaging Systems utilizes the many years of experience and product breakthroughs of its parent company’s clinical research services, and tailors their products to the unique requirements of direct patient care in healthcare and wellness environments.

Canfield Imaging Systems
800.815.4330
www.canfieldsci.com

Source: Canfield Imaging Systems

|| Next Entries »

Friday
July 4, 2008

Press Releases:

Syndication:

Admin:

the leading physician journal for aesthetics and wellness